These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 20384545
1. Emerging drugs for treatment of urinary incontinence. Vij M, Robinson D, Cardozo L. Expert Opin Emerg Drugs; 2010 Jun; 15(2):299-308. PubMed ID: 20384545 [Abstract] [Full Text] [Related]
2. Current management and future perspectives of overactive bladder (OAB) pharmacotherapy. Dobrek Ł, Juszczak K, Wyczółkowski M, Thor PJ. Acta Pol Pharm; 2011 Jun; 68(6):807-21. PubMed ID: 22125944 [Abstract] [Full Text] [Related]
3. Pharmacological treatment of overactive bladder: report from the International Consultation on Incontinence. Andersson KE, Chapple CR, Cardozo L, Cruz F, Hashim H, Michel MC, Tannenbaum C, Wein AJ. Curr Opin Urol; 2009 Jul; 19(4):380-94. PubMed ID: 19448545 [Abstract] [Full Text] [Related]
4. New drug treatments for urinary incontinence. Robinson D, Cardozo L. Maturitas; 2010 Apr; 65(4):340-7. PubMed ID: 20097022 [Abstract] [Full Text] [Related]
5. [Urinary incontinence: new pharmacologic therapies]. Robles García JE, Zudaire Bergera JJ, Rosell Costa D, Berián Polo JM. Rev Med Univ Navarra; 2004 Apr; 48(4):43-9. PubMed ID: 15812946 [Abstract] [Full Text] [Related]
11. Cizolirtine citrate is safe and effective for treating urinary incontinence secondary to overactive bladder: a phase 2 proof-of-concept study. Zát'ura F, Vsetica J, Abadías M, Pavlík I, Schraml P, Brod'ák M, Villoria J, Sust M, E-4018/CL50 Study Group. Eur Urol; 2010 Jan; 57(1):145-52. PubMed ID: 19446951 [Abstract] [Full Text] [Related]
12. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis. Wagg A, Wyndaele JJ, Sieber P. Am J Geriatr Pharmacother; 2006 Mar; 4(1):14-24. PubMed ID: 16730617 [Abstract] [Full Text] [Related]
13. Antimuscarinics for the treatment of overactive bladder: current options and emerging therapies. Hegde SS, Mammen M, Jasper JR. Curr Opin Investig Drugs; 2004 Jan; 5(1):40-9. PubMed ID: 14983972 [Abstract] [Full Text] [Related]
14. Antimuscarinic agents: implications and concerns in the management of overactive bladder in the elderly. Kay GG, Granville LJ. Clin Ther; 2005 Jan; 27(1):127-38; quiz 139-40. PubMed ID: 15763613 [Abstract] [Full Text] [Related]
15. Safety and tolerability of tolterodine for the treatment of overactive bladder in adults. Roberts RG, Garely AD, Bavendam T. Am J Manag Care; 2005 Jul; 11(4 Suppl):S158-62. PubMed ID: 16161389 [Abstract] [Full Text] [Related]
16. Pharmacologic management of urinary incontinence in the female. Rovner ES, Wein AJ. Minerva Ginecol; 2004 Aug; 56(4):327-47. PubMed ID: 15377982 [Abstract] [Full Text] [Related]
18. [News in the pharmacological treatment of female urinary incontinence]. Martan A. Cas Lek Cesk; 2006 Aug; 145(7):549-53. PubMed ID: 16921783 [Abstract] [Full Text] [Related]